Sierra Oncology
(NASDAQ) SRRA
Sierra Oncology Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$102.67M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SRRA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sierra Oncology
Industry
Biotechnology
Sector
Health CareEmployees
109
CEO
Stephen George Dilly, PhD
Website
www.sierraoncology.comHeadquarters
Vancouver, BC 94404, CA
SRRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-98%
Return on Capital
-98%
Return on Assets
-87%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$94.66M
EBITDA
$94.36M
Operating Cash Flow
$78.96M
Capital Expenditure
$72.00K
Free Cash Flow
$79.04M
Cash & ST Invst.
$104.75M
Total Debt
$853.00K
Sierra Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
109
N/A
Net Income
$27.93M
-40.2%
EBITDA
$27.85M
-40.7%
Quarterly Fundamentals
Net Cash
$268.40M
+150.1%
Accounts Receivable
$270.00K
+26.2%
Inventory
$0.00
N/A
Long Term Debt
$5.30M
+4242.6%
Short Term Debt
$318.00K
+48.6%
Return on Assets
-86.55%
N/A
Return on Invested Capital
-98.11%
N/A
Free Cash Flow
$25.80M
-52.1%
Operating Cash Flow
$25.74M
-51.7%